Countdown to Ethereum Pectra Upgrade Activation: Learn more
$2.61T
Total marketcap
$250.87B
Total volume
BTC 60.44%     ETH 7.28%
Dominance

FibroGen FGEN Stock

0.27 USD {{ price }} -2.464290% {{change_pct}}%
Exchange
NasdaqGS
Market Cap
27.56M USD
LOW - HIGH [24H]
0.25 - 0.28 USD
VOLUME [24H]
1.22M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-1.53 USD

FibroGen Price Chart

FibroGen FGEN Financial and Trading Overview

FibroGen stock price 0.27 USD
Previous Close 0.6 USD
Open 0.6 USD
Bid 0.42 USD x 200
Ask 0.72 USD x 200
Day's Range 0.55 - 0.6 USD
52 Week Range 0.18 - 2.93 USD
Volume 684.88K USD
Avg. Volume 1.41M USD
Market Cap 58.39M USD
Beta (5Y Monthly) 0.726
PE Ratio (TTM) N/A
EPS (TTM) -1.53 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 10 USD

FGEN Valuation Measures

Enterprise Value 103.85M USD
Trailing P/E N/A
Forward P/E -0.8397102
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 0.33590773
Price/Book (mrq) N/A
Enterprise Value/Revenue 0.597
Enterprise Value/EBITDA -0.626

Trading Information

FibroGen Stock Price History

Beta (5Y Monthly) 0.726
52-Week Change -24.11%
S&P500 52-Week Change 22.67%
52 Week High 2.93 USD
52 Week Low 0.18 USD
50-Day Moving Average 0.43 USD
200-Day Moving Average 0.72 USD

FGEN Share Statistics

Avg. Volume (3 month) 1.41M USD
Avg. Daily Volume (10-Days) 1.72M USD
Shares Outstanding 100.77M
Float 90.52M
Short Ratio 3.27
% Held by Insiders 0.84%
% Held by Institutions 55.03%
Shares Short 4.32M
Short % of Float 5.07%
Short % of Shares Outstanding 4.30%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2023
Most Recent Quarter (mrq) June 30, 2024
Next Fiscal Year End December 31, 2024

Profitability

Profit Margin -96.83%
Operating Margin (ttm) -21.56%
Gross Margin -34.39%
EBITDA Margin -95.40%

Management Effectiveness

Return on Assets (ttm) -26.54%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 173.82M USD
Revenue Per Share (ttm) 1.76 USD
Quarterly Revenue Growth (yoy) 14.29%
Gross Profit (ttm) -59789000 USD
EBITDA -165835008 USD
Net Income Avi to Common (ttm) -168324000 USD
Diluted EPS (ttm) -1.23
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 140.71M USD
Total Cash Per Share (mrq) 1.4 USD
Total Debt (mrq) 163.78M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 1.41
Book Value Per Share (mrq) -2.067

Cash Flow Statement

Operating Cash Flow (ttm) -202016000 USD
Levered Free Cash Flow (ttm) -121833376 USD

Profile of FibroGen

Country United States
State CA
City San Francisco
Address 409 Illinois Street
ZIP 94158
Phone 415 978 1200
Website https://www.fibrogen.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 486

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of locally advanced pancreatic cancer; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

Q&A For FibroGen Stock

What is a current FGEN stock price?

FibroGen FGEN stock price today per share is 0.27 USD.

How to purchase FibroGen stock?

You can buy FGEN shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for FibroGen?

The stock symbol or ticker of FibroGen is FGEN.

Which industry does the FibroGen company belong to?

The FibroGen industry is Biotechnology.

How many shares does FibroGen have in circulation?

The max supply of FibroGen shares is 100.92M.

What is FibroGen Price to Earnings Ratio (PE Ratio)?

FibroGen PE Ratio is now.

What was FibroGen earnings per share over the trailing 12 months (TTM)?

FibroGen EPS is -1.53 USD over the trailing 12 months.

Which sector does the FibroGen company belong to?

The FibroGen sector is Healthcare.

FibroGen FGEN included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 15603.26 USD
+0.1
10.08B USD 14784.03 USD 16292.28 USD 10.08B USD
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG 2497.76 USD
-0.11
2369.22 USD 2594.76 USD
NASDAQ Biotechnology NBI 3856.67 USD
-1.22
3700.88 USD 3966.57 USD
NASDAQ HealthCare IXHC 865.57 USD
-0.49
828.4 USD 890 USD
NASDAQ Biotechnology Total Retu XNBI 4172.84 USD
-1.22
4004.28 USD 4291.75 USD
Nasdaq US 700 Small Cap Index NQUS700SC 1913.4 USD
-1.32
1835.13 USD 2001.25 USD
NASDAQ Global Select Market Com NQGS 7634.31 USD
+0.11
7233.89 USD 7972.89 USD
Stlmt ID NASDAQ Biotechnology NBX 4153.28 USD
+1.21
4281.91 USD 4648.11 USD
NASDAQ Composite Total Return I XCMP 19098.57 USD
+0.1
18095.83 USD 19941.93 USD
NASDAQ Philippines Utilities Lg NQPH7000LMPHPT 1112.33 PHP 20 USD
<0.01
1112.33 PHP 20 USD 1112.33 PHP 20 USD